BIOBRAN MGN-3

Clinical Indication

Adjuvant to cancer treatment

Comments

Cancer Research UK statement

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.